The effects of statins on pulmonary artery pressure in patients with chronic obstructive pulmonary disease: a randomized controlled trial
A Arian, SGM Moghadam, T Kazemi… - Journal of research in …, 2017 - journals.lww.com
Objective: Pulmonary hypertension is a serious complication in patients suffering from
chronic obstructive pulmonary disease (COPD). The aim of this study is to investigate the
effects of atorvastatin in reducing pulmonary arterial pressure in COPD patients. Methods:
This double-blind, randomized trial was conducted on 42 known cases of COPD with
systolic pulmonary arterial pressure of more than 25 mmHg. The patients were randomly
assigned into two groups, 21 patients with atorvastatin treatment (40 mg/daily for 6 months) …
chronic obstructive pulmonary disease (COPD). The aim of this study is to investigate the
effects of atorvastatin in reducing pulmonary arterial pressure in COPD patients. Methods:
This double-blind, randomized trial was conducted on 42 known cases of COPD with
systolic pulmonary arterial pressure of more than 25 mmHg. The patients were randomly
assigned into two groups, 21 patients with atorvastatin treatment (40 mg/daily for 6 months) …
以上显示的是最相近的搜索结果。 查看全部搜索结果